Terms: = Lung cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Prognosis
51 results:
1. Association of the m
Li Y; Cao J; Wang J; Wu W; Jiang L; Sun X
Cancer; 2024 Feb; 130(3):356-374. PubMed ID: 37861451
[TBL] [Abstract] [Full Text] [Related]
2. Patritumab Deruxtecan (her3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast cancer: A Multicenter, Phase I/II Trial.
Krop IE; Masuda N; Mukohara T; Takahashi S; Nakayama T; Inoue K; Iwata H; Yamamoto Y; Alvarez RH; Toyama T; Takahashi M; Osaki A; Saji S; Sagara Y; O'Shaughnessy J; Ohwada S; Koyama K; Inoue T; Li L; Patel P; Mostillo J; Tanaka Y; Sternberg DW; Sellami D; Yonemori K
J Clin Oncol; 2023 Dec; 41(36):5550-5560. PubMed ID: 37801674
[TBL] [Abstract] [Full Text] [Related]
3. HERTHENA-lung01: a phase II study of patritumab deruxtecan (her3-DXd) in previously treated metastatic
Yu HA; Yang JC; Hayashi H; Goto Y; Felip E; Reck M; Vigliotti M; Dong Q; Cantero F; Fan PD; Kanai M; Sternberg DW; Jänne PA
Future Oncol; 2023 Jun; 19(19):1319-1329. PubMed ID: 37212796
[TBL] [Abstract] [Full Text] [Related]
4. Effect of short-term storage of blood samples on gene expression in lung cancer patients.
Obermayr E; Koppensteiner N; Heinzl N; Schuster E; Holzer B; Fabikan H; Weinlinger C; Illini O; Hochmair MJ; Zeillinger R
Clin Chem Lab Med; 2023 Jan; 61(2):294-301. PubMed ID: 36395488
[TBL] [Abstract] [Full Text] [Related]
5. Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid cancer in Children, Adolescents, and Young Adults.
Tian T; Huang S; Dai H; Qi M; Liu B; Huang R
J Clin Endocrinol Metab; 2023 Jan; 108(2):306-314. PubMed ID: 36226635
[TBL] [Abstract] [Full Text] [Related]
6. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.
Viktorsson K; Hååg P; Shah CH; Franzén B; Arapi V; Holmsten K; Sandström P; Lewensohn R; Ullén A
Mol Oncol; 2022 Oct; 16(20):3620-3641. PubMed ID: 35838333
[TBL] [Abstract] [Full Text] [Related]
7. erbb3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in cancer Cells.
Jung BK; Kim YJ; Hong J; Chang HG; Yoon AR; Yun CO
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806132
[TBL] [Abstract] [Full Text] [Related]
8. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract] [Full Text] [Related]
9. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
10. EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cells.
Gao L; Yang T; Zhang S; Liang Y; Shi P; Ren H; Hou P; Chen M
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907840
[TBL] [Abstract] [Full Text] [Related]
11. MiR-519d targets her3 and can be used as a potential serum biomarker for non-small cell lung cancer.
Wang A; Zhang H; Wang J; Zhang S; Xu Z
Aging (Albany NY); 2020 Mar; 12(6):4866-4878. PubMed ID: 32170048
[TBL] [Abstract] [Full Text] [Related]
12. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through her3 with a MAPK-dependent mechanism.
Lee L; Ramos-Alvarez I; Moody TW; Mantey SA; Jensen RT
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118625. PubMed ID: 31862538
[TBL] [Abstract] [Full Text] [Related]
13. Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.
Djureinovic D; Pontén V; Landelius P; Al Sayegh S; Kappert K; Kamali-Moghaddam M; Micke P; Ståhle E
BMC Cancer; 2019 Jul; 19(1):741. PubMed ID: 31357969
[TBL] [Abstract] [Full Text] [Related]
14. Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer.
Maisel SA; Broka D; Atwell B; Bunch T; Kupp R; Singh SK; Mehta S; Schroeder J
J Transl Med; 2019 Jun; 17(1):201. PubMed ID: 31215437
[TBL] [Abstract] [Full Text] [Related]
15. Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell lung cancer.
Sequist LV; Gray JE; Harb WA; Lopez-Chavez A; Doebele RC; Modiano MR; Jackman DM; Baggstrom MQ; Atmaca A; Felip E; Provencio M; Cobo M; Adiwijaya B; Kuesters G; Kamoun WS; Andreas K; Pipas JM; Santillana S; Cho BC; Park K; Shepherd FA
Oncologist; 2019 Aug; 24(8):1095-1102. PubMed ID: 30975923
[TBL] [Abstract] [Full Text] [Related]
16. SWI/SNF-Compromised cancers Are Susceptible to Bromodomain Inhibitors.
Shorstova T; Marques M; Su J; Johnston J; Kleinman CL; Hamel N; Huang S; Alaoui-Jamali MA; Foulkes WD; Witcher M
Cancer Res; 2019 May; 79(10):2761-2774. PubMed ID: 30877105
[TBL] [Abstract] [Full Text] [Related]
17. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
Wang W; Zhao HF; Yao TF; Gong H
Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
[TBL] [Abstract] [Full Text] [Related]
18. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
[TBL] [Abstract] [Full Text] [Related]
19. Design of cyclic and d-amino acids containing peptidomimetics for inhibition of protein-protein interactions of HER2-her3.
Pallerla S; Naik H; Singh S; Gauthier T; Sable R; Jois SD
J Pept Sci; 2018 Feb; 24(2):. PubMed ID: 29436155
[TBL] [Abstract] [Full Text] [Related]
20. HER2/her3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report.
Murata K; Kawahara A; Ono T; Takase Y; Abe H; Naito Y; Akiba J
Diagn Cytopathol; 2018 May; 46(5):429-433. PubMed ID: 29205961
[TBL] [Abstract] [Full Text] [Related]
[Next]
